Literature DB >> 11271368

Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease.

M Yamada1, S Hayashi, S Tsuji, H Takahashi.   

Abstract

Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder caused by expansion of a polyglutamine tract in the disease protein. In this study of brains from four autopsied MJD patients, we have demonstrated immunohistochemically that expanded polyglutamine stretches largely accumulate as inclusions in neuronal nuclei, and less frequently are distributed in the nucleoplasm in a diffuse pattern. These nuclear abnormalities involved many neurons covering a wide range of central and peripheral nervous system regions, including the cerebral cortex, thalamus and autonomic ganglia that have been categorized previously as spared regions by conventional pathological studies. These lesions, newly recognized by polyglutamine immunohistochemistry, may be responsible for the cerebral cortical dysfunctions or autonomic abnormalities pointed out in MJD patients by the recent clinical and neuroradiological studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11271368     DOI: 10.1007/s004010000277

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas.

Authors:  Pedro Braga-Neto; Lívia Almeida Dutra; José Luiz Pedroso; André C Felício; Helena Alessi; Ruth F Santos-Galduroz; Paulo Henrique F Bertolucci; Mário Luiz V Castiglioni; Rodrigo Affonseca Bressan; Griselda Esther Jara de Garrido; Orlando Graziani Povoas Barsottini; Andrea Jackowski
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

2.  Parametric fMRI of paced motor responses uncovers novel whole-brain imaging biomarkers in spinocerebellar ataxia type 3.

Authors:  João Valente Duarte; Ricardo Faustino; Mercês Lobo; Gil Cunha; César Nunes; Carlos Ferreira; Cristina Januário; Miguel Castelo-Branco
Journal:  Hum Brain Mapp       Date:  2016-06-07       Impact factor: 5.038

Review 3.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

4.  Dysautonomia is frequent in Machado-Joseph disease: clinical and neurophysiological evaluation.

Authors:  Karen A G Takazaki; Anelyssa D'Abreu; Anamarli Nucci; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

5.  Compromised mitochondrial complex II in models of Machado-Joseph disease.

Authors:  Mário N Laço; Catarina R Oliveira; Henry L Paulson; A Cristina Rego
Journal:  Biochim Biophys Acta       Date:  2011-10-20

6.  Longitudinal study on MRI intensity changes of Machado-Joseph disease: correlation between MRI findings and neuropathological changes.

Authors:  Yoshihiko Horimoto; Mitsuhiro Matsumoto; Hiroyasu Akatsu; Akihiro Kojima; Mari Yoshida; Kazuya Nokura; Hiroyuki Yuasa; Eiichi Katada; Takayuki Yamamoto; Kenji Kosaka; Yoshio Hashizume; Hiroko Yamamoto; Shigehisa Mitake
Journal:  J Neurol       Date:  2011-03-17       Impact factor: 4.849

Review 7.  Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  Veronica F Colomer Gould
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 8.  Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias.

Authors:  Veronica F Colomer Gould
Journal:  NeuroRx       Date:  2005-07

9.  Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry.

Authors:  Maria Pikkarainen; Päivi Hartikainen; Hilkka Soininen; Irina Alafuzoff
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

10.  Axonal inclusions in spinocerebellar ataxia type 3.

Authors:  Kay Seidel; Wilfred F A den Dunnen; Christian Schultz; Henry Paulson; Stefanie Frank; Rob A de Vos; Ewout R Brunt; Thomas Deller; Harm H Kampinga; Udo Rüb
Journal:  Acta Neuropathol       Date:  2010-07-16       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.